A. Juutilainen

发表

Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.

L. Moilanen, K. Savolainen, K. Pulkki, 2014, Clinica chimica acta; international journal of clinical chemistry.

Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women

M. Laakso, K. Pyörälä, S. Lehto, 2005, Diabetologia.

Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease

M. Laakso, J. Airaksinen, S. Lehto, 2014, BMC Cardiovascular Disorders.

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

M. Laakso, S. Lehto, T. Rönnemaa, 2007, Diabetologia.

Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2010, Diabetologia.

Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward

E. Jantunen, A. Juutilainen, M. Pyörälä, 2017, Infectious diseases.

Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study.

V. Salomaa, J. Tuomilehto, P. Jousilahti, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Preoperative atrial fibrillation in association with reduced haemoglobin predicts increased 30-d mortality after cardiac surgery

A. Juutilainen, J. Halonen, J. Räsänen, 2020, Scandinavian cardiovascular journal : SCJ.

Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women.

M. Laakso, S. Lehto, T. Rönnemaa, 2009, Atherosclerosis.

Cryoglobulinaemia and rapidly deteriorating renal function in chronic lymphocytic leukaemia.

A. Lumiaho, L. Karjalainen, A. Juutilainen, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis

L. Groop, V. Mohan, S. Ripatti, 2021, Diabetes Care.

Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies

J. Ilonen, M. Knip, J. Toppari, 2016, Diabetes.

High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study

M. Laakso, S. Lehto, T. Rönnemaa, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Procalcitonin is a useful marker of infection in neutropenia.

A. Juutilainen, I. Koivula, 2011, Leukemia research.

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics

E. Jantunen, K. Hanhineva, K. Pulkki, 2018, Disease markers.

Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up.

S. Lehto, H. Manninen, A. Juutilainen, 2012, European journal of radiology.

Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: Is volume loading needed?

L. Niskanen, L. Mykkänen, E. Voutilainen, 2005, Blood pressure.

Plasma copeptin in the assessment of febrile neutropenia

E. Jantunen, K. Pulkki, A. Juutilainen, 2012, Peptides.

Impact of minimal invasive extracorporeal circulation on perioperative intravenous fluid management in coronary artery bypass surgery

J. Hartikainen, T. Selander, A. Juutilainen, 2021, Perfusion.

Serial plasma lactate measurements in haematological patients with neutropenic fever

E. Jantunen, K. Pulkki, A. Juutilainen, 2010, Scandinavian journal of infectious diseases.

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia

E. Jantunen, K. Pulkki, A. Juutilainen, 2017, Disease markers.

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia

E. Jantunen, K. Pulkki, A. Juutilainen, 2017, Disease markers.

Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients

E. Jantunen, A. Juutilainen, T. Nousiainen, 2018, Infectious diseases.

MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia

E. Jantunen, K. Pulkki, P. Riikonen, 2019, Leukemia & lymphoma.

Secular Trends in Infection-Related Mortality after Kidney Transplantation.

P. Finne, P. Karhapää, A. Juutilainen, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C‐reactive protein

E. Ruokonen, E. Jantunen, A. Juutilainen, 2009, European journal of haematology.

Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever

E. Jantunen, K. Pulkki, A. Juutilainen, 2014, Leukemia & lymphoma.

Serum cortisol and inflammatory response in neutropenic fever

L. Niskanen, E. Jantunen, K. Pulkki, 2011, Annals of Hematology.

Thoracoabdominal Calcifications Predict Cardiovascular Disease Mortality in Type 2 Diabetic and Nondiabetic Subjects

M. Laakso, S. Lehto, T. Rönnemaa, 2009, Diabetes Care.

Prevention of Atrial Fibrillation After Cardiac Surgery: A Review of Literature and Comparison of Different Treatment Modalities.

J. Hartikainen, T. Vasankari, A. Juutilainen, 2022, Cardiology in review.

Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis

E. Jantunen, K. Pulkki, A. Juutilainen, 2011, Leukemia & lymphoma.

Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use

E. Jantunen, P. Mäntymaa, A. Juutilainen, 2012, Annals of Hematology.

Interleukin‐1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients

E. Jantunen, K. Pulkki, A. Juutilainen, 2018, European journal of haematology.

Physical Activity, High-Sensitivity C-Reactive Protein, and Total and Cardiovascular Disease Mortality in Type 2 Diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2011, Diabetes Care.

IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.

E. Jantunen, K. Pulkki, A. Juutilainen, 2012, Cytokine.

Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia

E. Jantunen, K. Pulkki, A. Juutilainen, 2011, Scandinavian journal of infectious diseases.

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Seppo Lehto, M. Laakso, S. Lehto, 2005, Diabetes care.

Gender difference in the impact of type 2 diabetes on coronary heart disease risk.

Seppo Lehto, M. Laakso, S. Lehto, 2004, Diabetes care.

Risk factors for end‐stage renal disease in a community‐based population: 26‐year follow‐up of 25 821 men and women in eastern Finland

V. Salomaa, P. Jousilahti, J. Tuomilehto, 2009, Journal of internal medicine.

Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia

E. Jantunen, K. Pulkki, A. Juutilainen, 2021, Clinical and Experimental Medicine.

Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C‐reactive protein, and blood culture findings

E. Jantunen, K. Pulkki, A. Juutilainen, 2020, European journal of haematology.

Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy

E. Jantunen, K. Pulkki, A. Juutilainen, 2011, European journal of haematology.

Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes

M. Laakso, S. Lehto, T. Rönnemaa, 2012, Journal of internal medicine.

High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients

E. Jantunen, K. Pulkki, A. Juutilainen, 2011, Haematologica.

Association of body mass index with 30-day mortality and red blood cell transfusions in open heart surgery

J. Hartikainen, A. Juutilainen, J. Halonen, 2023, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients

E. Jantunen, K. Pulkki, A. Juutilainen, 2017, Scandinavian journal of clinical and laboratory investigation.

Effector T Cell Resistance to Suppression and STAT3 Signaling during the Development of Human Type 1 Diabetes

J. Ilonen, M. Knip, J. Toppari, 2018, The Journal of Immunology.

Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients

E. Jantunen, K. Pulkki, A. Juutilainen, 2015, Infectious diseases.

Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women

Seppo Lehto, M. Laakso, S. Lehto, 2007, Diabetes Care.

Trends in estimated kidney function: the FINRISK surveys

V. Salomaa, J. Tuomilehto, P. Jousilahti, 2012, European Journal of Epidemiology.

Impact of perfusion method on perioperative red blood cell transfusions and new-onset postoperative atrial fibrillation in mitral valve surgery patients

J. Hartikainen, A. Juutilainen, J. Halonen, 2022, Perfusion.